IBDEI1SX ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30615,0)
 ;;=M62.40^^121^1522^11
 ;;^UTILITY(U,$J,358.3,30615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30615,1,3,0)
 ;;=3^Muscle Contracture,Unspec Site
 ;;^UTILITY(U,$J,358.3,30615,1,4,0)
 ;;=4^M62.40
 ;;^UTILITY(U,$J,358.3,30615,2)
 ;;=^5012631
 ;;^UTILITY(U,$J,358.3,30616,0)
 ;;=R68.89^^121^1522^8
 ;;^UTILITY(U,$J,358.3,30616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30616,1,3,0)
 ;;=3^General Signs & Symptoms,Other
 ;;^UTILITY(U,$J,358.3,30616,1,4,0)
 ;;=4^R68.89
 ;;^UTILITY(U,$J,358.3,30616,2)
 ;;=^5019557
 ;;^UTILITY(U,$J,358.3,30617,0)
 ;;=R39.89^^121^1522^9
 ;;^UTILITY(U,$J,358.3,30617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30617,1,3,0)
 ;;=3^Genitourinary System Signs & Symptoms,Other
 ;;^UTILITY(U,$J,358.3,30617,1,4,0)
 ;;=4^R39.89
 ;;^UTILITY(U,$J,358.3,30617,2)
 ;;=^5019350
 ;;^UTILITY(U,$J,358.3,30618,0)
 ;;=B02.23^^121^1523^1
 ;;^UTILITY(U,$J,358.3,30618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30618,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,30618,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,30618,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,30619,0)
 ;;=B02.22^^121^1523^2
 ;;^UTILITY(U,$J,358.3,30619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30619,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,30619,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,30619,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,30620,0)
 ;;=C15.9^^121^1524^8
 ;;^UTILITY(U,$J,358.3,30620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30620,1,3,0)
 ;;=3^Malig Neop Esophagus,Unspec
 ;;^UTILITY(U,$J,358.3,30620,1,4,0)
 ;;=4^C15.9
 ;;^UTILITY(U,$J,358.3,30620,2)
 ;;=^5000919
 ;;^UTILITY(U,$J,358.3,30621,0)
 ;;=C22.8^^121^1524^13
 ;;^UTILITY(U,$J,358.3,30621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30621,1,3,0)
 ;;=3^Malig Neop Liver,Primary,Unspec Type
 ;;^UTILITY(U,$J,358.3,30621,1,4,0)
 ;;=4^C22.8
 ;;^UTILITY(U,$J,358.3,30621,2)
 ;;=^5000939
 ;;^UTILITY(U,$J,358.3,30622,0)
 ;;=C22.0^^121^1524^5
 ;;^UTILITY(U,$J,358.3,30622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30622,1,3,0)
 ;;=3^Liver Cell Carcinoma
 ;;^UTILITY(U,$J,358.3,30622,1,4,0)
 ;;=4^C22.0
 ;;^UTILITY(U,$J,358.3,30622,2)
 ;;=^5000933
 ;;^UTILITY(U,$J,358.3,30623,0)
 ;;=C22.2^^121^1524^1
 ;;^UTILITY(U,$J,358.3,30623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30623,1,3,0)
 ;;=3^Hepatoblastoma
 ;;^UTILITY(U,$J,358.3,30623,1,4,0)
 ;;=4^C22.2
 ;;^UTILITY(U,$J,358.3,30623,2)
 ;;=^5000935
 ;;^UTILITY(U,$J,358.3,30624,0)
 ;;=C22.7^^121^1524^4
 ;;^UTILITY(U,$J,358.3,30624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30624,1,3,0)
 ;;=3^Liver Carcinomas,Oth Spec
 ;;^UTILITY(U,$J,358.3,30624,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,30624,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,30625,0)
 ;;=C32.9^^121^1524^9
 ;;^UTILITY(U,$J,358.3,30625,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30625,1,3,0)
 ;;=3^Malig Neop Larynx,Unspec
 ;;^UTILITY(U,$J,358.3,30625,1,4,0)
 ;;=4^C32.9
 ;;^UTILITY(U,$J,358.3,30625,2)
 ;;=^5000956
 ;;^UTILITY(U,$J,358.3,30626,0)
 ;;=C34.91^^121^1524^15
 ;;^UTILITY(U,$J,358.3,30626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30626,1,3,0)
 ;;=3^Malig Neop Right Bronchus/Lung
 ;;^UTILITY(U,$J,358.3,30626,1,4,0)
 ;;=4^C34.91
 ;;^UTILITY(U,$J,358.3,30626,2)
 ;;=^5000967
 ;;^UTILITY(U,$J,358.3,30627,0)
 ;;=C34.92^^121^1524^10
 ;;^UTILITY(U,$J,358.3,30627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30627,1,3,0)
 ;;=3^Malig Neop Left Bronchus/Lung
 ;;^UTILITY(U,$J,358.3,30627,1,4,0)
 ;;=4^C34.92
 ;;^UTILITY(U,$J,358.3,30627,2)
 ;;=^5000968
 ;;^UTILITY(U,$J,358.3,30628,0)
 ;;=C50.911^^121^1524^16
